2024/02/01 更新

写真a

タナカ トモヒロ
田中 智博
Tanaka Tomohiro
所属
医歯薬学域 准教授
職名
准教授
外部リンク

学位

  • 医学博士 ( 東京医科歯科大学 )

研究キーワード

  • ケミカルバイオロジー

  • 有機合成化学

研究分野

  • ライフサイエンス / 薬系化学、創薬科学

学歴

  • 東京医科歯科大学    

    2008年4月 - 2011年3月

      詳細を見る

  • 東京医科歯科大学    

    2006年4月 - 2008年3月

      詳細を見る

  • 東京薬科大学   School of Pharmacy  

    2002年4月 - 2006年3月

      詳細を見る

経歴

  • 岡山大学   学術研究院医歯薬学域   准教授

    2022年10月 - 現在

      詳細を見る

    国名:日本国

    researchmap

  • 東京理科大学   薬学部生命創薬科学科   助教

    2019年10月 - 2022年9月

      詳細を見る

  • 公益財団法人野口研究所   糖鎖有機化学研究室   研究員

    2016年3月 - 2019年9月

      詳細を見る

  • 東京理科大学   薬学部   ポスドク研究員

    2012年10月 - 2016年2月

      詳細を見る

  • ペンシルバニア大学   化学科   ポスドク研究員

    2011年5月 - 2012年9月

      詳細を見る

委員歴

  • 日本薬学会   ファルマシアトピックス小委員  

    2022年4月 - 現在   

      詳細を見る

    団体区分:学協会

    researchmap

 

論文

  • Design and Synthesis of Poly(2,2′-Bipyridyl) Ligands for Induction of Cell Death in Cancer Cells: Control of Anticancer Activity by Complexation/Decomplexation with Biorelevant Metal Cations

    Chandrasekar Balachandran, Masumi Hirose, Tomohiro Tanaka, Jun Jie Zhu, Kenta Yokoi, Yosuke Hisamatsu, Yasuyuki Yamada, Shin Aoki

    Inorganic Chemistry   2023年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:American Chemical Society (ACS)  

    DOI: 10.1021/acs.inorgchem.3c01738

    researchmap

  • Post-complexation Functionalization of Cyclometalated Iridium(III) Complexes and Applications to Biomedical and Material Sciences

    Shin Aoki, Kenta Yokoi, Yosuke Hisamatsu, Chandrasekar Balachandran, Yuichi Tamura, Tomohiro Tanaka

    Topics in Current Chemistry   380 ( 5 )   2022年10月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    DOI: 10.1007/s41061-022-00401-w

    researchmap

    その他リンク: https://link.springer.com/article/10.1007/s41061-022-00401-w/fulltext.html

  • Design, Synthesis and Biological Evaluation of Boron‐Containing Macrocyclic Polyamine Dimers and Their Zinc(II) Complexes for Boron Neutron Capture Therapy

    Hiroki Ueda, Minoru Suzuki, Yoshinori Sakurai, Tomohiro Tanaka, Shin Aoki

    European Journal of Inorganic Chemistry   2022 ( 5 )   2022年2月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    DOI: 10.1002/ejic.202100949

    researchmap

    その他リンク: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ejic.202100949

  • The structure of POMGNT2 provides new insights into the mechanism to determine the functional O ‐mannosylation site on α‐dystroglycan

    Rieko Imae, Naoyuki Kuwabara, Hiroshi Manya, Tomohiro Tanaka, Masato Tsuyuguchi, Mamoru Mizuno, Tamao Endo, Ryuichi Kato

    Genes to Cells   26 ( 7 )   485 - 494   2021年7月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Wiley  

    DOI: 10.1111/gtc.12853

    researchmap

    その他リンク: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/gtc.12853

  • Design, Synthesis, and Biological Evaluation of Boron-Containing Macrocyclic Polyamines and Their Zinc(II) Complexes for Boron Neutron Capture Therapy

    Hiroki Ueda, Minoru Suzuki, Reiko Kuroda, Tomohiro Tanaka, Shin Aoki

    Journal of Medicinal Chemistry   64 ( 12 )   8523 - 8544   2021年6月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:American Chemical Society (ACS)  

    DOI: 10.1021/acs.jmedchem.1c00445

    researchmap

  • Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro

    Kaho Shionoya, Masako Yamasaki, Shoya Iwanami, Yusuke Ito, Shuetsu Fukushi, Hirofumi Ohashi, Wakana Saso, Tomohiro Tanaka, Shin Aoki, Kouji Kuramochi, Shingo Iwami, Yoshimasa Takahashi, Tadaki Suzuki, Masamichi Muramatsu, Makoto Takeda, Takaji Wakita, Koichi Watashi

    Frontiers in Microbiology   12   2021年4月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Frontiers Media SA  

    Coronavirus disease 2019 (COVID-19) has caused serious public health, social, and economic damage worldwide and effective drugs that prevent or cure COVID-19 are urgently needed. Approved drugs including Hydroxychloroquine, Remdesivir or Interferon were reported to inhibit the infection or propagation of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), however, their clinical efficacies have not yet been well demonstrated. To identify drugs with higher antiviral potency, we screened approved anti-parasitic/anti-protozoal drugs and identified an anti-malarial drug, Mefloquine, which showed the highest anti-SARS-CoV-2 activity among the tested compounds. Mefloquine showed higher anti-SARS-CoV-2 activity than Hydroxychloroquine in VeroE6/TMPRSS2 and Calu-3 cells, with IC50 = 1.28 μM, IC90 = 2.31 μM, and IC99 = 4.39 μM in VeroE6/TMPRSS2 cells. Mefloquine inhibited viral entry after viral attachment to the target cell. Combined treatment with Mefloquine and Nelfinavir, a replication inhibitor, showed synergistic antiviral activity. Our mathematical modeling based on the drug concentration in the lung predicted that Mefloquine administration at a standard treatment dosage could decline viral dynamics in patients, reduce cumulative viral load to 7% and shorten the time until virus elimination by 6.1 days. These data cumulatively underscore Mefloquine as an anti-SARS-CoV-2 entry inhibitor.

    DOI: 10.3389/fmicb.2021.651403

    researchmap

  • Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

    Hirofumi Ohashi, Koichi Watashi, Wakana Saso, Kaho Shionoya, Shoya Iwanami, Takatsugu Hirokawa, Tsuyoshi Shirai, Shigehiko Kanaya, Yusuke Ito, Kwang Su Kim, Takao Nomura, Tateki Suzuki, Kazane Nishioka, Shuji Ando, Keisuke Ejima, Yoshiki Koizumi, Tomohiro Tanaka, Shin Aoki, Kouji Kuramochi, Tadaki Suzuki, Takao Hashiguchi, Katsumi Maenaka, Tetsuro Matano, Masamichi Muramatsu, Masayuki Saijo, Kazuyuki Aihara, Shingo Iwami, Makoto Takeda, Jane A. McKeating, Takaji Wakita

    iScience   24 ( 4 )   102367 - 102367   2021年4月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.isci.2021.102367

    researchmap

  • Development of metallosupramolecular phosphatases based on the combinatorial self-assembly of metal complexes and organic building blocks for the catalytic hydrolysis of phosphate monoesters

    Shin Aoki, Akib Bin Rahman, Yosuke Hisamatsu, Yuya Miyazawa, Mohd Zulkefeli, Yutaka Saga, Tomohiro Tanaka

    Results in Chemistry   3   100133 - 100133   2021年1月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.rechem.2021.100133

    researchmap

  • Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy

    Naoyuki Kuwabara, Rieko Imae, Hiroshi Manya, Tomohiro Tanaka, Mamoru Mizuno, Hiroki Tsumoto, Motoi Kanagawa, Kazuhiro Kobayashi, Tatsushi Toda, Toshiya Senda, Tamao Endo, Ryuichi Kato

    Nature Communications   11 ( 1 )   2020年1月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    Abstract

    α-Dystroglycan (α-DG) is a highly-glycosylated surface membrane protein. Defects in the O-mannosyl glycan of α-DG cause dystroglycanopathy, a group of congenital muscular dystrophies. The core M3 O-mannosyl glycan contains tandem ribitol-phosphate (RboP), a characteristic feature first found in mammals. Fukutin and fukutin-related protein (FKRP), whose mutated genes underlie dystroglycanopathy, sequentially transfer RboP from cytidine diphosphate-ribitol (CDP-Rbo) to form a tandem RboP unit in the core M3 glycan. Here, we report a series of crystal structures of FKRP with and without donor (CDP-Rbo) and/or acceptor [RboP-(phospho-)core M3 peptide] substrates. FKRP has N-terminal stem and C-terminal catalytic domains, and forms a tetramer both in crystal and in solution. In the acceptor complex, the phosphate group of RboP is recognized by the catalytic domain of one subunit, and a phosphate group on O-mannose is recognized by the stem domain of another subunit. Structure-based functional studies confirmed that the dimeric structure is essential for FKRP enzymatic activity.

    DOI: 10.1038/s41467-019-14220-z

    researchmap

    その他リンク: https://www.nature.com/articles/s41467-019-14220-z

  • Efficient synthesis of N- and O-linked glycopeptides using acid-labile Boc groups for the protection of carbohydrate moieties

    Tomohiro Tanaka, Mika Shiraishi, Akio Matsuda, Mamoru Mizuno

    Tetrahedron Letters   60 ( 40 )   151106 - 151106   2019年10月

     詳細を見る

    担当区分:筆頭著者   掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.tetlet.2019.151106

    researchmap

  • Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands. 査読

    Sakyiamah MM, Kobayakawa T, Fujino M, Konno M, Narumi T, Tanaka T, Nomura W, Yamamoto N, Murakami T, Tamamura H

    Bioorganic & medicinal chemistry   27 ( 6 )   1130 - 1138   2019年3月

  • Design, synthesis and biological evaluation of low molecular weight CXCR4 ligands

    Sakyiamah MM, Kobayakawa T, Fujino M, KonnoM, Narumi T, Tanaka T, Nomura W, Yamamoto N, Murakami T, Tamamura H

    ChemMedChem   8 ( 1 )   118 - 124   2019年

     詳細を見る

  • Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT). 査読

    Itoh T, Tamura K, Ueda H, Tanaka T, Sato K, Kuroda R, Aoki S

    Bioorganic & medicinal chemistry   26 ( 22 )   5922 - 5933   2018年12月

  • CDP-glycerol inhibits the synthesis of the functional O-mannosyl glycan of α-dystroglycan

    Rieko Imae, Hiroshi Manya, Hiroki Tsumoto, Kenji Osumi, Tomohiro Tanaka, Mamoru Mizuno, Motoi Kanagawa, Kazuhiro Kobayashi, Tatsushi Toda, Tamao Endo

    Journal of Biological Chemistry   293 ( 31 )   12186 - 12198   2018年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1074/jbc.ra118.003197

    researchmap

  • Bivalent 14-mer peptide ligands of CXCR4 with polyproline linkers with anti-chemotactic activity against Jurkat cells 査読

    Tomohiro Tanaka, Toru Aoki, Wataru Nomura, Hirokazu Tamamura

    JOURNAL OF PEPTIDE SCIENCE   23 ( 7-8 )   574 - 580   2017年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY  

    Interaction of CXCR4 with its endogenous ligand, stromal-cell derived factor-1 (SDF-1)/CXCL12, induces various physiological functions involving chemotaxis. Bivalent ligands with a polyproline helix bearing a cyclic pentapeptide, FC131, were previously shown to have higher binding affinities for CXCR4 than the corresponding monovalent ligands. Bivalent ligands based on a 14-mer peptide T140 derivative with polyproline linkers have been designed and synthesized. The activity of these peptides as well as the effect of bivalency of the ligand on CXCR4 binding has been assessed. The binding affinity of these series of bivalent ligands is increased as the linker length increases up to the 12-/15-mer proline linker. The inhibitory activity against chemotaxis on Jurkat cells also depends on the linker length. The T140-derived bivalent ligands with the 9- and 12-mer proline linkers showed the most effective inhibition against chemotaxis at 1000nM, which is even higher than that of known CXCR4 antagonists in the monomer structure. The effective metastatic inhibition by bivalent T140 derivatives indicates the therapeutic potential. Copyright (c) 2017 European Peptide Society and John Wiley & Sons, Ltd.

    DOI: 10.1002/psc.2946

    Web of Science

    PubMed

    researchmap

  • Concise and Versatile Synthesis of Sulfoquinovosyl Acyl Glycerol Derivatives for Biological Applications 査読

    Tomohiro Tanaka, Yasuhiro Sawamoto, Shin Aoki

    CHEMICAL & PHARMACEUTICAL BULLETIN   65 ( 6 )   566 - 572   2017年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PHARMACEUTICAL SOC JAPAN  

    Sulfoquinovosyl acylpropanediol (SQAP), a chemically modified analogue of sulfoquinovosyl acylglycerol (SQAG) that occurs in sea algae, has been reported to show a variety of biological activities, including accumulation in tumor cells and the inhibition of tumor cell growth. We report herein on a new concise and versatile synthesis of SQAP itself and derivatives bearing iodoaryl groups and boronclusters. This method should be useful for the design and synthesis of SQAG/SQAP derivatives for diagnosis and the treatment of cancer and related diseases.

    DOI: 10.1248/cpb.c17-00135

    Web of Science

    PubMed

    researchmap

  • B-11 NMR Probes of Copper(II): Finding and Implications of the Cu2+-Promoted Decomposition of ortho-Carborane Derivatives 査読

    Tomohiro Tanaka, Yukiko Nishiura, Rikita Araki, Takaomi Saido, Ryo Abe, Shin Aoki

    EUROPEAN JOURNAL OF INORGANIC CHEMISTRY   ( 12 )   1819 - 1834   2016年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-V C H VERLAG GMBH  

    The development of noninvasive methodologies for the detection of d-block metal ions such as copper (Cu2+), zinc (Zn2+), and manganese (Mn2+) is important for understanding their biological roles and relationship with diseases. We have been interested in the use of B-11 NMR probes for the detection of d-block metal ions, because B-11 is an ultratrace element in living systems. o-Carboranes, which consist of ten boron and two carbon atoms, have been applied to numerous drugs and biological active agents. In this work, we found that the o-carborane-pendant cyclens (L-3-L-5) (cyclen = 1,4,7,10-tetraazacyclododecane) are decomposed in the presence of Mn2+ or Cu2+ in aqueous solution at neutral pH, accompanied by the release of 4-9 equiv. of B(OH)(3). Furthermore, it was found that o-carborane derivatives that contain hydroxyl groups instead of a cyclen unit also undergo decomposition in the presence of Cu2+ and the corresponding complexes such as Cu(bpy) to afford 10 equiv. of B(OH)(3), as confirmed by B-11 NMR spectroscopic analysis and an azomethine-H assay. These reactions are applied to B-11 MRI (magnetic resonance imaging) probes for Cu2+.

    DOI: 10.1002/ejic.201600117

    Web of Science

    researchmap

  • Development of a traceable linker containing a thiol-responsive amino acid for the enrichment and selective labelling of target proteins 査読

    Jun Yamamoto, Masaya Denda, Nami Maeda, Miku Kita, Chiaki Komiya, Tomohiro Tanaka, Wataru Nomura, Hirokazu Tamamura, Youichi Sato, Aiko Yamauchi, Akira Shigenaga, Akira Otaka

    ORGANIC & BIOMOLECULAR CHEMISTRY   12 ( 23 )   3821 - 3826   2014年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ROYAL SOC CHEMISTRY  

    A traceable linker that is potentially applicable to identification of a target protein of bioactive compounds was developed. It enabled not only thiol-induced cleavage of the linker for enrichment of the target protein but also selective labelling to pick out the target from contaminated non-target proteins for facile identification.

    DOI: 10.1039/c4ob00622d

    Web of Science

    PubMed

    researchmap

  • Development of a fluoride-responsive amide bond cleavage device that is potentially applicable to a traceable linker 査読

    Yamamoto, J, Maeda, N, Komiya, C, Tanaka, T, Denda, M, Ebisuno, K, Nomura, W, Tamamura, H, Sato, Y, Yamauchi, A, Shigenaga, A, Otaka, A

    Tetrahedron   70   5122 - 5127   2014年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.tet.2014.05.110

    researchmap

  • Cell-permeable stapled peptides based on HIV-1 integrase inhibitors derived from HIV-1 Gene products 査読

    Wataru Nomura, Haruo Aikawa, Nami Ohashi, Emiko Urano, Mathieu Métifiot, Masayuki Fujino, Kasthuraiah Maddali, Taro Ozaki, Ami Nozue, Tetsuo Narumi, Chie Hashimoto, Tomohiro Tanaka, Yves Pommier, Naoki Yamamoto, Jun A. Komano, Tsutomu Murakami, Hirokazu Tamamura

    ACS Chemical Biology   8 ( 10 )   2235 - 2244   2013年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:American Chemical Society  

    HIV-1 integrase (IN) is an enzyme which is indispensable for the stable infection of host cells because it catalyzes the insertion of viral DNA into the genome and thus is an attractive target for the development of anti-HIV agents. Earlier, we found Vpr-derived peptides with inhibitory activity against HIV-1 IN. These Vpr-derived peptides are originally located in an α-helical region of the parent Vpr protein. Addition of an octa-arginyl group to the inhibitory peptides caused significant inhibition against HIV replication associated with an increase in cell permeability but also relatively high cytotoxicity. In the current study, stapled peptides, a new class of stabilized α-helical peptidomimetics were adopted to enhance the cell permeability of the above lead peptides. A series of stapled peptides, which have a hydrocarbon link formed by a ruthenium-catalyzed ring-closing metathesis reaction between successive turns of α-helix, were designed, synthesized, and evaluated for biological activity. In cell-based assays some of the stapled peptides showed potent anti-HIV activity comparable with that of the original octa-arginine-containing peptide (2) but with lower cytotoxicity. Fluorescent imaging experiments revealed that these stapled peptides are significantly cell permeable, and CD analysis showed they form α-helical structures, whereas the unstapled congeners form β-sheet structures. The application of this stapling strategy to Vpr-derived IN inhibitory peptides led to a remarkable increase in their potency in cells and a significant reduction of their cytotoxicity. © 2013 American Chemical Society.

    DOI: 10.1021/cb400495h

    Scopus

    PubMed

    researchmap

  • Biological Effects of Bivalent-type CXCR4 Ligands with Rigid Linkers 査読

    Nomura W, Tanaka T, Aoki T, Narumi T, Tamamura H

    BIOPOLYMERS   100 ( 3 )   296 - 296   2013年5月

     詳細を見る

    記述言語:英語  

    researchmap

  • 腫瘍認識プローブ・HIV阻害剤としてのケモカイン受容体リガンド 査読

    野村 渉, 田中 智博, 大橋 南美, 玉村 啓和

    生体材料工学研究所年報   46   28 - 31   2013年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:東京医科歯科大学生体材料工学研究所  

    researchmap

  • Low-Molecular-Weight CXCR4 Ligands with Variable Spacers 査読

    Tetsuo Narumi, Haruo Aikawa, Tomohiro Tanaka, Chie Hashimoto, Nami Ohashi, Wataru Nomura, Takuya Kobayakawa, Hikaru Takano, Yuki Hirota, Tsutomu Murakami, Naoki Yamamoto, Hirokazu Tamamura

    ChemMedChem   8 ( 1 )   118 - 124   2013年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Low-molecular-weight CXCR4 ligands based on known lead compounds including the 14-mer peptide T140, the cyclic pentapeptide FC131, peptide mimetics, and dipicolylamine-containing compounds were designed and synthesized. Three types of aromatic spacers, 1,4-phenylenedimethanamine, naphthalene-2,6-diyldimethanamine, and [1,1′-biphenyl]-4,4′-diyldimethanamine, were used to build four pharmacophore groups. As pharmacophore groups, 2-pyridylmethyl and 1-naphthylmethyl are present in all of the compounds, and several aromatic groups and a cationic group from 1-propylguanidine and 1,1,3,3-tetramethyl-2-propylguanidine were also used. Several compounds showed significant CXCR4 binding affinity, and zinc(II) complexation of bis(pyridin-2-ylmethyl)amine moieties resulted in a remarkable increase in CXCR4 binding affinity. © 2013 WILEY-VCH Verlag GmbH &amp
    Co. KGaA, Weinheim.

    DOI: 10.1002/cmdc.201200390

    Scopus

    PubMed

    researchmap

  • Bivalent ligands for the chemokine receptor CXCR4 dimer and their function 査読

    Nomura W, Tanaka T, Aikawa H, Narumi T, Tamamura H

    JOURNAL OF PEPTIDE SCIENCE   18   S47 - S47   2012年9月

     詳細を見る

    記述言語:英語  

    researchmap

  • HIV inhibitors targeting entry, fusion, and integrase 査読

    Narumi Tetsuo, Tanaka Tomohiro, Nomura Wataru, Aikawa Haruo, Tamamura Hirokazu

    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY   244   2012年8月

  • Pharmacophore-based small molecule CXCR4 ligands 査読

    Tetsuo Narumi, Tomohiro Tanaka, Chie Hashimoto, Wataru Nomura, Haruo Aikawa, Akira Sohma, Kyoko Itotani, Miyako Kawamata, Tsutomu Murakami, Naoki Yamamoto, Hirokazu Tamamura

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   22 ( 12 )   4169 - 4172   2012年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Low molecular weight CXCR4 ligands were developed based on the peptide T140, which has previously been identified as a potent CXCR4 antagonist. Some compounds with naphthyl, fluorobenzyl and pyridyl moieties as pharmacophore groups in the molecule showed significant CXCR4-binding activity and anti-HIV activity. Structure-activity relationships were studied and characteristics of each of these three moieties necessary for CXCR4 binding were defined. In this way, CXCR4 ligands with two types of recognition modes for CXCR4 have been found. (C) 2012 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2012.04.032

    Web of Science

    PubMed

    researchmap

  • Conjugation of cell-penetrating peptides leads to identification of anti-HIV peptides from matrix proteins 査読

    Tetsuo Narumi, Mao Komoriya, Chie Hashimoto, Honggui Wu, Wataru Nomura, Shintaro Suzuki, Tomohiro Tanaka, Joe Chiba, Naoki Yamamoto, Tsutomu Murakami, Hirokazu Tamamura

    BIOORGANIC & MEDICINAL CHEMISTRY   20 ( 4 )   1468 - 1474   2012年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Compounds which inhibit the HIV-1 replication cycle have been found amongst fragment peptides derived from an HIV-1 matrix (MA) protein. Overlapping peptide libraries covering the whole sequence of MA were designed and constructed with the addition of an octa-arginyl group to increase their cell membrane permeability. Imaging experiments with fluorescent-labeled peptides demonstrated these peptides with an octa-arginyl group can penetrate cell membranes. The fusion of an octa-arginyl group was proven to be an efficient way to find active peptides in cells such as HIV-inhibitory peptides. (C) 2011 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmc.2011.12.055

    Web of Science

    PubMed

    researchmap

  • A Synthetic C34 Trimer of HIV-1 gp41 Shows Significant Increase in Inhibition Potency 査読

    Wataru Nomura, Chie Hashimoto, Aki Ohya, Kosuke Miyauchi, Emiko Urano, Tomohiro Tanaka, Tetsuo Narumi, Toru Nakahara, Jun A. Komano, Naoki Yamamoto, Hirokazu Tamamura

    CHEMMEDCHEM   7 ( 2 )   205 - 208   2012年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    DOI: 10.1002/cmdc.201100542

    Web of Science

    PubMed

    researchmap

  • The successes and failures of HIV drug discovery 査読

    Chie Hashimoto, Tomohiro Tanaka, Tetsuo Narumi, Wataru Nomura, Hirokazu Tamamura

    EXPERT OPINION ON DRUG DISCOVERY   6 ( 10 )   1067 - 1090   2011年10月

     詳細を見る

    記述言語:英語   出版者・発行元:INFORMA HEALTHCARE  

    Introduction: To date, several anti-human immunodeficiency virus (HIV) drugs, including reverse transcriptase inhibitors and protease inhibitors, have been developed and used clinically for the treatment of patients infected with HIV. Recently, novel drugs have been discovered which have different mechanisms of action from those of the above inhibitors, including entry inhibitors and integrase (IN) inhibitors; the clinical use of three of these inhibitors has been approved. Other inhibitors are still in development.
    Areas covered: This review article summarizes the history of the development of anti-HIV drugs and also focuses on successes in the development of these entry and IN inhibitors, along with looking at exploratory approaches for the development of other inhibitors.
    Expert opinion: Currently used highly active antiretroviral therapy can be subject to a loss of efficacy, due to the emergence of multi-drug resistant (MDR) strains; a change of regimens of the drug combination is required to combat this, along with careful monitoring of the virus and CD4 in the blood, by methods such as cellular tropism testing. In such a situation, entry inhibitors such as CCR5/CXCR4 antagonists, CD4 mimics, fusion inhibitors and IN inhibitors might be optional agents for an expansion of the drug repertoire available to patients at all stages of HIV infection.

    DOI: 10.1517/17460441.2011.611129

    Web of Science

    PubMed

    researchmap

  • Azamacrocyclic Metal Complexes as CXCR4 Antagonists 査読

    Tomohiro Tanaka, Tetsuo Narumi, Taro Ozaki, Akira Sohma, Nami Ohashi, Chie Hashimoto, Kyoko Itotani, Wataru Nomura, Tsutomu Murakami, Yamamoto B. Naoki, Hirokazu Tamamura

    CHEMMEDCHEM   6 ( 5 )   834 - 839   2011年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    The chemokine receptor CXCR4 is a member of the seven transmembrane GPCR family, which is implicated in multiple diseases, including HIV infection, cancers, and rheumatoid arthritis. Low-molecular-weight nonpeptidic compounds, including AMD3100 and various pyridyl macrocyclic zinc(II) complexes, have been identified as selective antagonists of CXCR4. In the present study, structure-activity relationship studies were performed by combining the common structural features of alkylamino and pyridiyl macrocyclic antagonists. Several new zinc(II) or copper(II) complexes demonstrated potent anti-HIV activity, strong CXCR4-binding activity, and significant inhibitory activity against Ca(2+) mobilization induced by CXCL12 stimulation. These results may prove useful in the design of novel CXCR4 antagonists, and the compounds described could potentially be developed as therapeutics against CXCR4-relevant diseases or chemical probes to study the biological activity of CXCR4.

    DOI: 10.1002/cmdc.201000548

    Web of Science

    PubMed

    researchmap

  • Design and Synthesis of Traceable Linker for Efficient Enrichment and Specific Labeling of Target Proteins 査読

    Yamamoto Jun, Tanaka Tomohiro, Denda Masaya, Shigenaga Akira, Nomura Wataru, Tamamura Hirokazu, Otaka Akira

    BIOPOLYMERS   96 ( 4 )   492   2011年

  • Development of Bivalent Ligands for CXCR4 with Rigid Linkers and Application to Detection of Cancer Cells 査読

    Nomura Wataru, Tomohiro Tanaka, Akemi Masuda, Tetsuo Narumi, Hirokazu Tamamura

    BIOPOLYMERS   96 ( 4 )   510 - 511   2011年

  • Bivalent Ligands of CXCR4 with Rigid Linkers for Elucidation of the Dimerization State in Cells 査読

    Tomohiro Tanaka, Wataru Nomura, Tetsuo Narumi, Akemi Masuda, Hirokazu Tamamura

    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY   132 ( 45 )   15899 - 15901   2010年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER CHEMICAL SOC  

    To date, challenges in the design of bivalent ligands for G protein-coupled receptors (GPCRs) have revealed difficulties stemming from lack of knowledge of the state of oligomerization of the GPCR. The synthetic bivalent ligands with rigid linkers that are presented here can predict the dimer form of CXCR4 and be applied to molecular probes in cancerous cells. This "molecular ruler" approach would be useful in elucidating the details of CXCR4 oligomer formation.

    DOI: 10.1021/ja107447w

    Web of Science

    PubMed

    researchmap

  • HIV-1遺伝子産物由来のインテグラーゼ阻害剤の創出 査読

    橋本 知恵, 田中 智博, 浦野 恵美子, 尾崎 太郎, 新井 啓之, 鳴海 哲夫, 野村 渉, Maddali Kasthuraiah, Pommier Yves, 山本 直樹, 駒野 淳, 玉村 啓和

    日本エイズ学会誌   12 ( 4 )   370 - 370   2010年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本エイズ学会  

    researchmap

  • gp120のCD4結合サイトを模倣した新規抗原分子の創製 査読

    尾崎 太郎, 田中 智博, 宮内 浩典, 橋本 知恵, 鳴海 哲夫, 野村 渉, 山本 直樹, 駒野 淳, 玉村 啓和

    日本エイズ学会誌   12 ( 4 )   484 - 484   2010年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本エイズ学会  

    researchmap

  • HIV-1侵入過程の動的超分子機構を基にした新規エイズワクチンの創製 査読

    橋本 知恵, 鳴海 哲夫, 野村 渉, 中原 徹, 田中 智博, 大庭 賢二, 相馬 晃, 長谷山 正樹, 村上 努, 山本 直樹, 玉村 啓和

    日本エイズ学会誌   12 ( 4 )   483 - 483   2010年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本エイズ学会  

    researchmap

  • CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist 査読

    Tetsuo Narumi, Chihiro Ochiai, Kazuhisa Yoshimura, Shigeyoshi Harada, Tomohiro Tanaka, Wataru Nomura, Hiroshi Arai, Taro Ozaki, Nami Ohashi, Shuzo Matsushita, Hirokazu Tamamura

    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS   20 ( 19 )   5853 - 5858   2010年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Small molecules behaving as CD4 mimics were previously reported as HIV-1 entry inhibitors that block the gp120-CD4 interaction and induce a conformational change in gp120, exposing its co-receptor-binding site. A structure-activity relationship (SAR) study of a series of CD4 mimic analogs was conducted to investigate the contribution from the piperidine moiety of CD4 mimic 1 to anti-HIV activity, cytotoxicity, and CD4 mimicry effects on conformational changes of gp120. In addition, several hybrid molecules based on conjugation of a CD4 mimic analog with a selective CXCR4 antagonist were also synthesized and their utility evaluated. (C) 2010 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmcl.2010.07.106

    Web of Science

    researchmap

  • Peptidic HIV integrase inhibitors derived from HIV gene products: Structure-activity relationship studies 査読

    Shintaro Suzuki, Kasthuraiah Maddali, Chie Hashimoto, Emiko Urano, Nami Ohashi, Tomohiro Tanaka, Taro Ozaki, Hiroshi Arai, Hiroshi Tsutsumi, Tetsuo Narumi, Wataru Nomura, Naoki Yamamoto, Yves Pommier, Jun A. Komano, Hirokazu Tamamura

    BIOORGANIC & MEDICINAL CHEMISTRY   18 ( 18 )   6771 - 6775   2010年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PERGAMON-ELSEVIER SCIENCE LTD  

    Structure-activity relationship studies were conducted on HIV integrase (IN) inhibitory peptides which were found by the screening of an overlapping peptide library derived from HIV-1 gene products. Since these peptides located in the second helix of Vpr are considered to have an alpha-helical conformation, Glu-Lys pairs were introduced into the i and i + 4 positions to increase the helicity of the lead compound possessing an octa-arginyl group. Ala-scan was also performed on the lead compound for the identification of the amino acid residues responsible for the inhibitory activity. The results indicated the importance of an a-helical structure for the expression of inhibitory activity, and presented a binding model of integrase and the lead compound. (C) 2010 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.bmc.2010.07.050

    Web of Science

    researchmap

  • Peptide HIV-1 integrase inhibitors from HIV-1 gene products. 査読

    Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H

    Journal of medicinal chemistry   53 ( 14 )   5356 - 5360   2010年7月

  • Remodeling of Dynamic Structures of HIV-1 Envelope Proteins Leads to Synthetic Antigen Molecules Inducing Neutralizing Antibodies 査読

    Toru Nakahara, Wataru Nomura, Kenji Ohba, Aki Ohya, Tomohiro Tanaka, Chie Hashimoto, Tetsuo Narumi, Tsutomu Murakami, Naoki Yamamoto, Hirokazu Tamamura

    BIOCONJUGATE CHEMISTRY   21 ( 4 )   709 - 714   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER CHEMICAL SOC  

    A synthetic antigen targeting membrane-fusion mechanism of HIV-1 has a newly designed template with C3-symmetric linkers mimicking N36 trimeric form. The antiserum produced by immunization of the N36 trimeric form antigen showed structural preference in binding to N36 trimer and stronger inhibitory activity against HIV-1 infection than the N36 monomer. Our results suggest an effective strategy of HIV vaccine design based on a relationship to the native structure of proteins involved in HIV fusion mechanisms.

    DOI: 10.1021/bc900502z

    Web of Science

    PubMed

    researchmap

  • エイズワクチンを指向した宿主受容体CXCR4由来抗原分子の創製 査読

    橋本 知恵, 野村 渉, 田中 智博, 中原 徹, 鳴海 哲夫, 大庭 賢二, 村上 努, 山本 直樹, 玉村 啓和

    日本薬学会年会要旨集   130年会 ( 2 )   71 - 71   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • 合成抗原ペプチドによるHIV-1 gp41の三量体構造を認識する抗体の誘導 査読

    野村 渉, 中原 徹, 大矢 亜紀, 大庭 賢二, 田中 智博, 橋本 知恵, 鳴海 哲夫, 村上 努, 山本 直樹, 玉村 啓和

    日本薬学会年会要旨集   130年会 ( 2 )   114 - 114   2010年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • CD4 mimics targeting the mechanism of HIV entry. 査読

    Yamada Y, Ochiai C, Yoshimura K, Tanaka T, Ohashi N, Narumi T, Nomura W, Harada S, Matsushita S, Tamamura H

    Bioorganic & medicinal chemistry letters   20 ( 1 )   354 - 358   2010年1月

  • Beyond antibodyという研究領域 ペプチドミメティクを基盤とした阻害剤と新規概念によるワクチン 査読

    玉村 啓和, 野村 渉, 鳴海 哲夫, 田中 智博, 駒野 淳, 山本 直樹

    日本生化学会大会プログラム・講演要旨集   82回   1S4a - 4   2009年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    researchmap

  • センシングバイオロジーを指向した蛍光性CXCR4プローブの創出とリガンドスクリーニング法の開発 査読

    堤 浩, 野村 渉, 田中 智博, 田部 泰章, 糸谷 恭子, 玉村 啓和

    生体材料工学研究所年報   42   3 - 7   2009年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:東京医科歯科大学生体材料工学研究所  

    researchmap

  • Fluorogenically Active Leucine Zipper Peptides as Tag-Probe Pairs for Protein Imaging in Living Cells 査読

    Hiroshi Tsutsumi, Wataru Nomura, Seiichiro Abe, Tomoaki Mino, Akemi Masuda, Nami Ohashi, Tomohiro Tanaka, Kenji Ohba, Naoki Yamamoto, Kazunari Akiyoshi, Hirokazu Tamamura

    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION   48 ( 48 )   9164 - 9166   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-V C H VERLAG GMBH  

    DOI: 10.1002/anie.200903183

    Web of Science

    researchmap

  • Development of chemokine receptor CXCR4 antagonists using bio-mimetic strategy. 査読

    Tamamura H, Tanaka T, Tsutsumi H, Ohashi N, Hiramatsu K, Araki T, Ojida A, Hamachi I, Wang Z, Peiper SC, Trent JO, Ueda S, Oishi S, Fujii N

    Advances in experimental medicine and biology   611   145 - 146   2009年

  • Stereoselective synthesis of peptidomimetics based on acid-catalyzed ring-opening of beta-aziridinyl-alpha,beta-enoates. 査読

    Tamamura H, Tanaka T, Tsutsumi H, Nemoto K, Mizokami S, Ohashi N, Oishi S, Fujii N

    Advances in experimental medicine and biology   611   149 - 150   2009年

     詳細を見る

  • Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids 査読

    Tomohiro Tanaka, Wataru Nomura, Tetsuo Narumi, Ai Esaka, Shinya Oishi, Nami Ohashi, Kyoko Itotani, Barry J. Evans, Zi-xuan Wang, Stephen C. Peiper, Nobutaka Fujii, Hirokazu Tamamura

    ORGANIC & BIOMOLECULAR CHEMISTRY   7 ( 18 )   3805 - 3809   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ROYAL SOC CHEMISTRY  

    Previously, downsizing of a 14-residue peptidic CXCR4 antagonist 1 has led to the development of a highly potent CXCR4 antagonist 2 [cyclo(-D-Tyr(1)-Arg(2)-Arg(3)-Nal(4)-Gly(5)-)]. In the present study, cyclic pentapeptide libraries that were designed by substitutions of several amino acids for D-Tyr(1) and Arg(2) in peptide 2 were prepared and screened to evaluate binding activity for CXCR4. The above structure-activity relationship study led to the finding of several potent CXCR4 ligands.

    DOI: 10.1039/b908286g

    Web of Science

    researchmap

  • A future perspective on the development of chemokine receptor CXCR4 antagonists 査読

    Hirokazu Tamamura, Hiroshi Tsutsumi, Wataru Nomura, Tomohiro Tanaka, Nobutaka Fujii

    EXPERT OPINION ON DRUG DISCOVERY   3 ( 10 )   1155 - 1166   2008年10月

     詳細を見る

    記述言語:英語   出版者・発行元:INFORMA HEALTHCARE  

    Background: In the postgenome era, G-protein-coupled receptor families have been recognized as significant drug targets in medicinal chemistry. A specific chemokine receptor, CXCR4, has multiple critical functions in normal physiologies including embryonic development of the cardiovascular, hemopoietic and central nervous systems, and underlies problematic pathologies such as HIV infection, cancer metastasis, leukemia progression and rheumatoid arthritis. Methods and results: A tetradecamer peptide, T140, derived from the horseshoe crab, and its biologically stable derivative, 4F-benzoyl-TN14003, were found to be powerful CXCR4 antagonists that block HIV entry to cells. These peptides have also shown remarkable inhibitory activity against cancer metastasis and progression in a variety of cancers. Slow release administration of 4F-benzoyl-TN14003, for example, was found to significantly reduce pulmonary metastasis of breast cancer cells in severe combined immunodeficient mice. This peptide also shows inhibitory effects against melanoma metastasis and Epstein-Barr virus-associated lymphoproliferation in mice, suppresses the delayed-type hypersensitivity response induced by sheep red blood cells and reduced collagen-induced arthritis in both mouse models of arthritis. Conclusion: T140 analogues have the potential to become promising agents for chemotherapy of AIDS, cancer and rheumatoid arthritis. This review summarizes the development of low molecular weight CXCR4 antagonists based on pharmacophore identification in T140 analogues and also provides an opinion on the future of the development of CXCR4 antagonists.

    DOI: 10.1517/17460440802373379

    Web of Science

    PubMed

    researchmap

  • Fluorophore labeling enables imaging and evaluation of specific CXCR4-ligand interaction at the cell membrane for fluorescence-based screening 査読

    Wataru Nomura, Yasuaki Tanabe, Hiroshi Tsutsumi, Tomohiro Tanaka, Kenji Ohba, Naoki Yamamoto, Hirokazu Tamamura

    BIOCONJUGATE CHEMISTRY   19 ( 9 )   1917 - 1920   2008年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER CHEMICAL SOC  

    Development of CXCR4-specific ligands is an important issue in chemotherapy of HIV infection, cancer metastasis, and rheumatoid arthritis, and numerous potential ligands have been developed to date. However, it is difficult to assess their binding mode and specificity because of uncertainties in the structure of the CXCR4-ligand complexes. To address this problem, we have synthesized fluorophore labeled Ac-TZ14011, which is derived from T140, a powerful CXCR4 antagonist. Binding of Ac-TZ14011 to CXCR4 on the cell membrane was observed by fluorescence microscope, and analysis of the binding data produced IC50 values of several ligands comparable to those obtained in RI-based assays. This fluorescence-based assay is applicable to explore new pharmacophores of CXCR4-specific ligands with high-throughput screening and also to screening of the other GPCR binding ligands.

    DOI: 10.1021/bc800216p

    Web of Science

    PubMed

    researchmap

  • HIV侵入の動的超分子機構を標的としたCD4 mimic small moleculeの創製 査読

    山田 裕子, 吉村 和久, 田中 智博, 堤 浩, 野村 渉, 糸谷 恭子, 増野 弘幸, 柴田 潤二, 畑田 万紀子, 松下 修三, 玉村 啓和

    日本薬学会年会要旨集   128年会 ( 2 )   84 - 84   2008年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    researchmap

  • Structure-activity relationship study of CXCR4 antagonists bearing the cyclic pentapeptide scaffold: identification of the new pharmacophore 査読

    Tomohiro Tanaka, Hiroshi Tsutsumi, Wataru Nomura, Yasuaki Tanabe, Nami Ohashi, Ai Esaka, Chihiro Ochiai, Jun Sato, Kyoko Itotani, Tsutomu Murakami, Kenji Ohba, Naoki Yamamoto, Nobutaka Fujii, Hirokazu Tamamura

    ORGANIC & BIOMOLECULAR CHEMISTRY   6 ( 23 )   4374 - 4377   2008年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ROYAL SOC CHEMISTRY  

    A highly potent CXCR4 antagonist 2 [cyclo (-D-Tyr(1)-Arg(2)-Arg(3)-Nal(4)-Gly(5)-)] has previously been identified by screening cyclic pentapeptide libraries that were designed based on pharmacophore residues of a 14-residue peptidic CXCR4 antagonist 1. In the present study, D-Tyr and Arg in peptide 2 were replaced by a bicyclic aromatic amino acid and a cationic amino acid, respectively, and their binding activity for CXCR4 was evaluated for identification of the novel pharmacophore.

    DOI: 10.1039/b812029c

    Web of Science

    researchmap

  • Versatile Use of Acid-catalyzed Ring-opening of -Aziridinyl-,-enoates to Stereoselective Synthesis of Peptidomimetics 査読

    Hirokazu Tamamura, Tomohiro Tanaka, Hiroshi Tsutsumi, Koji Nemoto, Satoko Mizokami, Nami Ohashi, Shinya Oishi, Nobutaka Fujii

    63 ( 37 )   9243 - 9254   2007年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.tet.2007.06.029

    Web of Science

    researchmap

  • Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents 招待 査読

    Hiroshi Tsutsumi, Tomohiro Tanaka, Nami Ohashi, Hiroyuki Masuno, Hirokazu Tamamura, Kenichi Hiramatsu, Takanobu Araki, Satoshi Ueda, Shinya Oishi, Nobutaka Fujii

    BIOPOLYMERS   88 ( 2 )   279 - 289   2007年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:JOHN WILEY & SONS INC  

    The chemokine receptor CXCR4 possesses multiple critical functions in normal and pathological physiology. CXCR4 is a G-protein-coupled receptor that transduces signals of its endogenous ligand, the chemokine CXC12 (stromal cell-derived factor-1, SDF-1). The interaction between CXC12 and CXCR4 plays an important role in the migration of progenitors during embryologic development of the cardiovascular, hemopoietic, central nervous systems, and so on. This interaction is also known to be involved in several intractable disease processes, including HIV infection, cancer cell metastasis, leukemia cell progression, rheumatoid arthritis (RA), and pulmonary fibrosis. It is conjectured that this interaction may be a critical therapeutical target in all of these diseases, and several CXCR4 antagonists have been proposed as potential drugs. Fourteen-mer peptides, T140 and its analogues, were previously developed in our laboratory as specific CXCR4 antagonists that were identified as HIV-entry inhibitors, anti-cancer-metastatic agents, anti-chronic lymphotic/acute lymphoblastic leukemia agents, and anti-RA agents. Cyclic pentapeptides, such as FC131 [cyclo(D-Tyr-Arg-Arg-L-3-(2-naphthyl)alanine-Gly)], were also previously found as CXCR4 antagonist leads based on pharmacophores of T140. This review article describes the elucidation of multiple functions of CXCR4 antagonists and the development of a number of low-molecular weight CXCR4 antagonists involving FC131 analogues and other compounds with different scaffolds including linear-type structures. (c) 2006 Wiley Periodicals, Inc.

    DOI: 10.1002/bip.20653

    Web of Science

    PubMed

    researchmap

▼全件表示

MISC

  • CDP-glycerolはα-ジストログリカンの糖鎖伸長を阻害する

    今江 理恵子, 萬谷 博, 津元 裕樹, 田中 智博, 水野 真盛, 金川 基, 小林 千浩, 戸田 達史, 遠藤 玉夫

    日本生化学会大会プログラム・講演要旨集   91回   [1P - 033]   2018年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • 福山型筋ジストロフィー原因遺伝子産物fukutinのグリセロールリン酸転移活性

    萬谷 博, 今江 理恵子, 津元 裕樹, 田中 智博, 水野 真盛, 金川 基, 小林 千浩, 戸田 達史, 遠藤 玉夫

    日本筋学会学術集会プログラム・抄録集   4回   162 - 162   2018年8月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本筋学会  

    J-GLOBAL

    researchmap

  • 筋ジストロフィー症原因遺伝子産物フクチンはジストログリカン糖鎖にグリセロールリン酸を導入する活性を有する

    今江 理恵子, 萬谷 博, 津元 裕樹, 田中 智博, 水野 真盛, 金川 基, 小林 千浩, 戸田 達史, 遠藤 玉夫

    日本薬学会年会要旨集   138年会 ( 3 )   105 - 105   2018年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本薬学会  

    J-GLOBAL

    researchmap

  • HIV阻害剤・腫瘍認識プローブとしてのケモカイン受容体リガンド 招待

    野村 渉, 田中智博, 玉村啓和

    ペプチド医薬の最前線,(株)シーエムシー出版   101 - 107   2012年12月

     詳細を見る

    記述言語:日本語   掲載種別:記事・総説・解説・論説等(学術雑誌)  

    researchmap

  • Corrigendum: A Synthetic C34 Trimer of HIV-1 gp41 Shows Significant Increase in Inhibition Potency

    Wataru Nomura, Chie Hashimoto, Aki Ohya, Kosuke Miyauchi, Emiko Urano, Tomohiro Tanaka, Tetsuo Narumi, Toru Nakahara, Jun A. Komano, Naoki Yamamoto, Hirokazu Tamamura

    ChemMedChem   7   546 - 546   2012年4月

  • 最新ペプチド合成技術とその創薬研究への応用. 招待

    野村 渉, 田中智博, 相川春夫, 玉村啓和

    多価結合型GPCRリガンドの合成とがん細胞イメージングへの応用(株式会社 メディカルドゥ   267 - 273   2012年

     詳細を見る

    記述言語:日本語   掲載種別:記事・総説・解説・論説等(学術雑誌)  

    researchmap

  • フッ化物イオン応答型アミノ酸の開発と標的タンパク質精製ツールへの応用

    山本純, 田中智博, 傳田将也, 戎野紘司, 重永章, 野村渉, 玉村啓和, 大高章

    日本薬学会年会要旨集   132nd ( 2 )   2012年

     詳細を見る

  • 標的タンパク質の効率的濃縮と同定を指向したトレーサブルリンカーの開発

    山本純, 前田奈美, 田中智博, 傳田将也, 重永章, 野村渉, 玉村啓和, 大高章

    日本薬学会年会要旨集   131st ( 2 )   2011年

     詳細を見る

  • HIV-gp41の三量体構造に特異的な中和抗体を誘導する人工抗原ペプチド

    野村渉, 相馬晃, 中原徹, 中原徹, 大庭賢二, 田中智博, 橋本知恵, 橋本知恵, 鳴海哲夫, 山本直樹, 玉村啓和, 玉村啓和

    日本薬学会関東支部大会講演要旨集   54th   2010年

     詳細を見る

  • HIV侵入の動的超分子機構を模倣した立体構造特異的人工抗原分子の創製

    野村渉, 中原徹, 橋本知恵, 相馬晃, 田中智博, 鳴海哲夫, 玉村啓和, 大庭賢二, 山本直樹

    反応と合成の進歩シンポジウム講演要旨集   36th   2010年

     詳細を見る

  • HIV-1コレセプターCXCR4を基にした人工設計型抗原分子の開発

    橋本知恵, 橋本知恵, 堤浩, 田中智博, 中原徹, 中原徹, 野村渉, 大庭賢二, 村上努, 山本直樹, 玉村啓和, 玉村啓和

    日本薬学会年会要旨集   129th ( 2 )   2009年

     詳細を見る

  • HIV-1コレセプターCXCR4を基にした人工設計型抗原分子の開発

    橋本知恵, 橋本知恵, 野村渉, 田中智博, 中原徹, 中原徹, 鳴海哲夫, 大庭賢二, 村上努, 山本直樹, 玉村啓和, 玉村啓和

    日本薬理学会関東部会プログラム・要旨集   120th   2009年

     詳細を見る

  • HIV-gp41の三量体構造に特異的な中和抗体を誘導する人工抗原ペプチド

    大矢亜紀, 中原徹, 中原徹, 野村渉, 大庭賢二, 田中智博, 橋本知恵, 橋本知恵, 鳴海哲夫, 村上努, 山本直樹, 玉村啓和, 玉村啓和

    メディシナルケミストリーシンポジウム講演要旨集   28th   2009年

     詳細を見る

  • HIV-1第二受容体CXCR4を基にした合成抗原分子の開発

    橋本知恵, 橋本知恵, 野村渉, 田中智博, 鳴海哲夫, 大庭賢二, 山本直樹, 玉村啓和, 玉村啓和

    メディシナルケミストリーシンポジウム講演要旨集   28th   2009年

     詳細を見る

  • CXCR4特異的蛍光プローブの開発と薬剤スクリーニングへの応用

    田中智博, 野村渉, 田部泰明, 田部泰明, 鳴海哲夫, 糸谷恭子, 大庭賢二, 山本直樹, 玉村啓和, 玉村啓和

    日本薬理学会関東部会プログラム・要旨集   120th   2009年

     詳細を見る

  • 蛍光性CXCR4特異的リガンドの開発:スクリーニング及びイメージングへの展開

    田中智博, 野村渉, 田部泰章, 田部泰章, 堤浩, 糸谷恭子, 大庭賢二, 村上努, 山本直樹, 玉村啓和, 玉村啓和

    日本薬学会年会要旨集   129th ( 2 )   2009年

     詳細を見る

  • 蛍光標識PKCおよび光制御型ケージドジアシルグリセロール誘導体の合成と機能評価

    大橋南美, 芹澤雄樹, 野村渉, 堤浩, 松本洋典, 奥田善章, 田中智博, 古田寿昭, 玉村啓和

    反応と合成の進歩シンポジウム講演要旨集   34th   190 - 191   2008年10月

     詳細を見る

  • 新規pharmacophoreを有するCXCR4アンタゴニストの構造活性相関研究

    田中智博, 田部泰章, 大橋南美, 長谷山正樹, 堤浩, 野村渉, 糸谷恭子, 江坂藍, 大石真也, 藤井信孝, WANG Z, PEIPER S C, EVANS B, 玉村啓和

    日本薬学会年会要旨集   128th ( 2 )   84   2008年3月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • 蛍光性アンタゴニストを用いたCXCR4のイメージングと阻害剤のスクリーニング法の確立

    田部泰章, 野村渉, 堤浩, 田中智博, 大庭賢二, 駒野淳, 山本直樹, 藤井信孝, 玉村啓和

    日本化学会講演予稿集   88th ( 2 )   2008年

     詳細を見る

  • 標的タンパク質を特異的に蛍光検出する新規タグ‐プローブシステムの開発

    堤浩, 大橋南美, 田中智博, 田部泰章, 阿部清一朗, 蓑友明, 玉村啓和

    反応と合成の進歩シンポジウム講演要旨集   33rd   306 - 307   2007年10月

     詳細を見る

  • Stereoselective synthesis of peptidomimetics based on acid-catalyzed ring-opening of beta-aziridinyl-alpha, beta-enoates

    H. Tamamura, T. Tanaka, H. Tsutsumi, K. Nemoto, S. Mizokami, N. Ohashi

    BIOPOLYMERS   88 ( 4 )   580 - 580   2007年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JOHN WILEY & SONS INC  

    Web of Science

    researchmap

  • Development of chemokine receptor CXCR4 antagonists using bio-mimetic strategy

    H. Tamamura, T. Tanaka, H. Tsutsumi, N. Ohashi, K. Hiramatsu, T. Araki, A. Ojida, I. Hamachi, Z. Wang, S. C. Pelper, J. O. Trent, S. Ueda, S. Oishi, N. Fujii

    BIOPOLYMERS   88 ( 4 )   577 - 577   2007年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:JOHN WILEY & SONS INC  

    Web of Science

    researchmap

▼全件表示

講演・口頭発表等

  • ホウ素中性子線捕捉療法に資するナノ粒子型10B薬剤の開発

    田中 智博, 上田 大貴, 鈴木 実, 櫻井 良憲, 上田 真史, 青木 伸

    第62回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会  2023年10月29日 

     詳細を見る

    開催年月日: 2023年10月28日 - 2023年10月29日

    researchmap

  • 大環状ポリアミン型のホウ素中性子捕捉療法(BNCT)用含ホウ素薬剤の設計と合成

    青木伸, 上田大貴, 田中智博, 鈴木実, 櫻井良憲

    第39回メディシナルケミストリーシンポジウム  2022年11月23日 

     詳細を見る

    開催年月日: 2022年11月23日 - 2022年11月25日

    researchmap

  • Design and Synthesis of Boron-Containing Macrocyclic Polyamines as Boron Neutron Capture Therapy (BNCT) Agents 招待

    Shin Aoki, Hiroki Ueda, Tomohiro Tanaka, Minoru Suzuki, Yoshinori Sakurai

    2022年11月25日 

     詳細を見る

    開催年月日: 2022年11月22日 - 2022年11月27日

    researchmap

  • ホウ素中性子捕捉療法のためのDNA標的型ホウ素薬剤の開発

    上田大貴, 鈴木実, 櫻井良憲, 田中智博, 青木伸

    第18回日本中性子捕捉療法学会学術大会  2022年10月18日 

     詳細を見る

    開催年月日: 2022年10月17日 - 2022年10月18日

    researchmap

共同研究・競争的資金等の研究

  • 銅(II)イオン検出のためのシグナル増幅系11B NMR/MRIプローブの創製

    研究課題/領域番号:16K18915  2016年04月 - 2018年03月

    日本学術振興会  科学研究費助成事業  若手研究(B)

    田中 智博

      詳細を見る

    配分額:2730000円 ( 直接経費:2100000円 、 間接経費:630000円 )

    生体内微量金属イオンは生体機能の維持に重要な役割を果たしており、疾患等によりその濃度は増減する事が知られている。中でも、銅(II)イオンは遺伝性疾患やがん、アルツハイマー病などの多くの疾患との関与が報告されている。そのため、銅(II)イオンの非侵襲的な検出法の開発は種々の生命現象の解析及び種々の疾患の診断において非常に有用である。そこで、本研究では銅(II)イオンによるカルボラン分解反応に基づき設計した銅(II)イオン検出のための11B NMR/MRI分子プローブの開発研究を行った。

    researchmap

 

担当授業科目

  • ヒトのからだの仕組みと診断 (2023年度) 第1学期  - 月3~4

  • 分析科学・物理化学 (2023年度) 特別  - その他

  • 分析科学4 (2023年度) 第1学期  - 木3~4

  • 分析科学4 (2023年度) 第1学期  - 木3~4

  • 分析科学C (2023年度) 第1学期  - 木3~4

  • 分析科学C (2023年度) 第1学期  - 木3~4

  • 創薬・育薬特別演習(生体機能分析学) (2023年度) 特別  - その他

  • 基礎物理学 (2023年度) 第1学期  - 火5~6,金3~4

  • 基礎物理学 (2023年度) 第1学期  - 火5~6,金3~4

  • 放射医薬品学1 (2023年度) 第3学期  - 月3~4

  • 無機・放射医薬品学 (2023年度) 3・4学期  - 月3~4

  • 無機・放射医薬品学 (2023年度) 3・4学期  - 月3~4

  • 物理系基礎実習 (2023年度) 第1学期  - その他5~9

  • 物理系基礎実習 (2023年度) 第1学期  - その他5~9

  • 生体機能分析学 (2023年度) 特別  - その他

  • 生体機能分析学特論 (2023年度) 特別  - その他

▼全件表示